Stimulation of hair regrowth in an animal model of androgenic alopecia using 2-deoxy-D-ribose.
2-deoxy-D-ribose
C57BL6 mice
androgenic alopecia
chemotherapy
hair regrowth
minoxidil
testosterone
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2024
2024
Historique:
received:
15
01
2024
accepted:
24
04
2024
medline:
18
6
2024
pubmed:
18
6
2024
entrez:
18
6
2024
Statut:
epublish
Résumé
Androgenic alopecia (AGA) affects both men and women worldwide. New blood vessel formation can restore blood supply and stimulate the hair regrowth cycle. Recently, our group reported that 2-deoxy-D-ribose (2dDR) is 80%-90% as effective as VEGF in the stimulation of neovascularization in
Identifiants
pubmed: 38887556
doi: 10.3389/fphar.2024.1370833
pii: 1370833
pmc: PMC11180715
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1370833Informations de copyright
Copyright © 2024 Anjum, Zulfiqar, Chaudhary, Rehman, Bullock, Yar and MacNeil.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
EMBO Mol Med. 2019 Oct;11(10):e11031
pubmed: 31512803
Expert Opin Pharmacother. 2004 Apr;5(4):933-40
pubmed: 15102575
Int J Biol Macromol. 2010 Mar 1;46(2):199-205
pubmed: 19941890
Phytother Res. 2014 Jul;28(7):1088-95
pubmed: 24375856
Pharmacotherapy. 2014 Dec;34(12):e341-4
pubmed: 25280267
Biol Reprod. 2001 Oct;65(4):1014-9
pubmed: 11566721
J Tissue Eng Regen Med. 2020 Jul;14(7):973-988
pubmed: 32473079
Spectrochim Acta A Mol Biomol Spectrosc. 2011 Nov;82(1):63-8
pubmed: 21803645
Dev Cell. 2010 Apr 20;18(4):633-42
pubmed: 20412777
J Clin Aesthet Dermatol. 2018 Jul;11(7):32-35
pubmed: 30057663
Eur J Dermatol. 2001 Jul-Aug;11(4):315-20
pubmed: 11399537
J Am Acad Dermatol. 2002 Feb;46(2):309-12
pubmed: 11807448
J Vis Exp. 2013 Feb 04;(72):e50225
pubmed: 23407542
Biochem Biophys Res Commun. 2006 Mar 31;342(1):280-5
pubmed: 16480951
Int J Pharm. 2009 Jan 5;365(1-2):100-8
pubmed: 18790031
Microvasc Res. 2020 Sep;131:104035
pubmed: 32593538
Regen Med. 2019 Mar;14(3):179-197
pubmed: 30793662
J Biomater Appl. 2019 Oct;34(4):463-475
pubmed: 31262210
Jpn Heart J. 2000 Jul;41(4):519-23
pubmed: 11041102
J Dermatol Sci. 2004 Apr;34(2):91-8
pubmed: 15033191
J Invest Dermatol. 2001 Jul;117(1):3-15
pubmed: 11442744
Mol Cell Endocrinol. 2018 Apr 15;465:122-133
pubmed: 28912032
Postepy Dermatol Alergol. 2014 Aug;31(4):207-15
pubmed: 25254005
Eur J Pharm Biopharm. 2016 Jul;104:51-8
pubmed: 27108784
Cancer Res. 2004 Mar 1;64(5):1794-801
pubmed: 14996742
Biomed Pharmacother. 2021 May;137:111247
pubmed: 33517191
Biomed Pharmacother. 2017 May;89:438-446
pubmed: 28249244
Int J Mol Sci. 2018 Sep 11;19(9):
pubmed: 30208587
Recent Pat Inflamm Allergy Drug Discov. 2012 May;6(2):130-6
pubmed: 22409453
Support Care Cancer. 2012 Oct;20(10):2349-56
pubmed: 22179546
Eur J Cancer Care (Engl). 2013 Jul;22(4):503-12
pubmed: 23528018
Endocrine. 2017 Jul;57(1):9-17
pubmed: 28349362
Int J Mol Sci. 2021 Oct 23;22(21):
pubmed: 34768868
Skin Appendage Disord. 2018 Oct;4(4):245-260
pubmed: 30410891
Biomedicines. 2019 Apr 08;7(2):
pubmed: 30965624
Skin Pharmacol Physiol. 2006;19(2):106-21
pubmed: 16685150
Dermatol Ther. 2016 Nov;29(6):424-432
pubmed: 27424565
Int J Clin Pharmacol Ther. 2016 Jan;54(1):19-27
pubmed: 26636418
Arch Dermatol Res. 2020 Jul;312(5):337-352
pubmed: 31786711
Molecules. 2017 Sep 08;22(9):
pubmed: 28885585